Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07473674 · ClinicalTrials.gov registry record · NA

Skin Prick Test to Evaluate Immunogenic Response of SILURCLOUD™ Fibrous Collagen Matrix in Healthy Volunteers

A NA study of Healthy Adult, sponsored by SerenaGroup.

Recruiting
Registry status
NA
Development phase
8
Enrollment target
1
Study location

NCT07473674 is a NA study of Healthy Adult that is actively recruiting participants, run by SerenaGroup. The registered enrollment target is 8 participants, below the 73-participant average among 8 other Healthy Adult trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07473674, a NA study of Healthy Adult, is actively recruiting participants, sponsored by SerenaGroup.

RECRUITING
Registry status
NA
Development phase
8 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to evaluate whether the SILURCLOUD™ Fibrous Collagen Matrix causes an allergic skin response in healthy adult volunteers. The main question it aims to answer is: Does the SILURCLOUD™ Fibrous Collagen Matrix produce a measurable allergic reaction following a skin prick test? Participants will: Undergo a skin prick test on the inner forearm using the study product and control substances Remain at the clinic for evaluation of the skin response approximately 15 minutes and 6 hours after application Return to the clinic 24-48 hours later for a final skin assessment The study will include healthy adult volunteers, including participants with Fitzpatrick Skin Type VI, to provide additional safety information requested by the U.S. FDA.

Conditions Studied

Interventions

  • DRUG Glycerosaline
  • DEVICE Collagen Matrix Skin Prick Test Device
  • DRUG Histamine

Study Locations (1)

Pennsylvania

  • SerenaGroup Monroeville - Monroeville

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2026-02
Est. Completion 2026-03
Phase NA

Sponsor

SerenaGroup

10 total trials

What the Registry Record Tells You About NCT07473674

The ClinicalTrials.gov registry entry for NCT07473674 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 73-participant average among 8 other Healthy Adult trials with a reported enrollment target (89% lower). The listed sponsor is SerenaGroup, which has 10 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy Adult appearing as the primary indexed condition, and to 3 interventions - of which Glycerosaline is the first listed.

NCT07473674 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT07473674 about?

NCT07473674 is a clinical study titled "Skin Prick Test to Evaluate Immunogenic Response of SILURCLOUD™ Fibrous Collagen Matrix in Healthy Volunteers". The goal of this clinical trial is to evaluate whether the SILURCLOUD™ Fibrous Collagen Matrix causes an allergic skin response in healthy adult volunteers. The main question it aims to answer is: Does the SILURCLOUD™ Fibrous Collagen Matrix produce a measurable allergic reaction following a skin p...

What is the current status of trial NCT07473674?

This trial is currently recruiting. It is a NA study. The enrollment target is 8 participants. The study started on 2026-02. Estimated completion is 2026-03.

What conditions does trial NCT07473674 study?

This clinical trial studies the following conditions: Healthy Adult.

What interventions are being tested in trial NCT07473674?

The interventions under investigation include: Glycerosaline (DRUG), Collagen Matrix Skin Prick Test Device (DEVICE), Histamine (DRUG).

Who is sponsoring clinical trial NCT07473674?

This trial is sponsored by SerenaGroup, which has 10 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07473674 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy Adult

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.